Cyclerion Therapeutics (CYCN) Q3 2025 Earnings

Screener

Reported November 12, 2025 · Before market open

Revenue$875.0K

EPS-$0.30

Next report

Nov 11, 2026 (in 2 months)

Revenue estimate$900.0K

EPS estimate-$6.00

Versus estimates

Revenue

Q4 2025$100.0KIn line Q1 2024$100.0KIn line

Q3 2025$875.0K

Diluted EPS

Q2 2026-$0.41Beat by $6.69 Q1 2026-$0.76Beat by $16.44 Q4 2025-$0.19Beat by $0.19 Q1 2024-$0.38In line

Q3 2025-$0.30

FAQ

When did Cyclerion Therapeutics report Q3 2025 earnings?: Cyclerion Therapeutics (CYCN) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Cyclerion Therapeutics's Q3 2025 revenue and EPS?: Cyclerion Therapeutics reported revenue of $875.0K and eps of $-0.30 for Q3 2025.
How did Cyclerion Therapeutics's Q3 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 351.0% from $194.0K a year earlier and eps declined 3.4% from $-0.29.
Where can I find Cyclerion Therapeutics's Q3 2025 SEC filings?: You can read the 10-Q periodic report (0001193125-25-277749) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Cyclerion Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk